-20%Sold out
Methyl Folate
400 mcg, 60 Veggie Caps
Original price was: 43,000 MMK.34,400 MMKCurrent price is: 34,400 MMK.
Methyl Folate ((6S)-5-methyltetrahydrofolate or (6S)-5-MTHF) is a highly biologically active form of folate. Due to the body’s limited ability to convert synthetic folic acid into the active form of folate, supplementation with (6S)-5-MTHF is preferable.
- Brand : Jarrow Formulas
- Item Form : Capsule
- Primary Supplement Type : Jarrow Formulas Extra Strength Methyl Folate 400 mcg, Dietary Supplement for Cardiovascular and Neurologic Health Support
Out of stock
Description
Jarrow Vegan Methyl Folate Extra Strength delivers 400 mcg of stable, bioavailable folate in each serving. Methyl folate is the most biologically active form of folic acid. Quatrefolic(R) is the fourth generation development in folate delivery. With certain inherited errors in metabolism and under a variety of physiologic stresses, the transformation of folic acid into the active form of folate either does not properly take place or is inadequate. This form of folate can cross the blood-brain barrier. Methyl Folate is needed to support cardiovascular and neurological health and proper cell division. No wheat, gluten, soybeans, dairy, egg, fish/shellfish, peanuts/tree nuts or sesame.
- Features Quatrefolic
- More stable, more bioavailable form of folate
- Gluten Free
- Non-GMO
Suggested Use :
Adults take 1 capsule once a day with or without food or as directed by your qualified healthcare professional. Store in a cool, dry place.
Additional information
| Strength |
400 mcg |
|---|---|
| Unit Count |
60 Veggie Caps |
Reviews (0)
Shipping & Delivery
Related products
Sold out
Select options
This product has multiple variants. The options may be chosen on the product page
Vitamin B-12 Methylcobalamin
1 mg, 500 mcg, 100 vegetarian Lozenges, 60 Vegetarian Lozenges
Price range: 29,000 MMK through 30,000 MMKSold out
Select options
This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.